BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 26176936)

  • 1. Biomarker Development for Chronic Obstructive Pulmonary Disease. From Discovery to Clinical Implementation.
    Sin DD; Hollander Z; DeMarco ML; McManus BM; Ng RT
    Am J Respir Crit Care Med; 2015 Nov; 192(10):1162-70. PubMed ID: 26176936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptomics, proteomics and metabolomics driven biomarker discovery in COPD: an update.
    Ghosh N; Dutta M; Singh B; Banerjee R; Bhattacharyya P; Chaudhury K
    Expert Rev Mol Diagn; 2016 Aug; 16(8):897-913. PubMed ID: 27267972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood and sputum protein biomarkers for chronic obstructive pulmonary disease (COPD).
    Moon JY; Leitao Filho FS; Shahangian K; Takiguchi H; Sin DD
    Expert Rev Proteomics; 2018 Nov; 15(11):923-935. PubMed ID: 30362838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Promise of Observational Studies (ECLIPSE, SPIROMICS, and COPDGene) in Achieving the Goal of Personalized Treatment of Chronic Obstructive Pulmonary Disease.
    Rennard SI
    Semin Respir Crit Care Med; 2015 Aug; 36(4):478-90. PubMed ID: 26238636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomarker Development in COPD: Moving From P Values to Products to Impact Patient Care.
    Hollander Z; DeMarco ML; Sadatsafavi M; McManus BM; Ng RT; Sin DD
    Chest; 2017 Feb; 151(2):455-467. PubMed ID: 27693595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Challenges of Precision Medicine in COPD.
    Cazzola M; Calzetta L; Rogliani P; Matera MG
    Mol Diagn Ther; 2017 Aug; 21(4):345-355. PubMed ID: 28247183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Drug Development Using Dynamic Biomarkers to Enable Personalized Health Care in COPD.
    Bihlet AR; Karsdal MA; Bay-Jensen AC; Read S; Kristensen JH; Sand JMB; Leeming DJ; Andersen JR; Lange P; Vestbo J
    Chest; 2015 Jul; 148(1):16-23. PubMed ID: 25856563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systematic review on recent potential biomarkers of chronic obstructive pulmonary disease.
    Aydindogan E; Penque D; Zoidakis J
    Expert Rev Mol Diagn; 2019 Jan; 19(1):37-45. PubMed ID: 30560707
    [No Abstract]   [Full Text] [Related]  

  • 9. Biomarkers in chronic obstructive pulmonary disease.
    Rosenberg SR; Kalhan R
    Transl Res; 2012 Apr; 159(4):228-37. PubMed ID: 22424427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic and biochemical markers of obstructive lung disease in the general population.
    Dahl M
    Clin Respir J; 2009 Apr; 3(2):121-2. PubMed ID: 20298391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Expert Meeting on COPD: Personalized Treatment of COPD - Wishful Thinking or Reality?].
    Lorenz J; Bals R; Ewert R; Jany B; Koczulla AR; Köhnlein T; Randerath WJ; Steinkamp G; Watz H; Welte T
    Pneumologie; 2016 Oct; 70(10):638-650. PubMed ID: 27723914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomarkers in Chronic Obstructive Pulmonary Disease: The Gateway to Precision Medicine.
    Milne S; Sin DD
    Clin Chest Med; 2020 Sep; 41(3):383-394. PubMed ID: 32800193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biomarkers for precision medicine in airways disease.
    Rooney C; Sethi T
    Ann N Y Acad Sci; 2015 Jun; 1346(1):18-32. PubMed ID: 26099690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Precision medicine in COPD: where are we and where do we need to go?
    Sidhaye VK; Nishida K; Martinez FJ
    Eur Respir Rev; 2018 Sep; 27(149):. PubMed ID: 30068688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of chronic obstructive pulmonary disease exacerbations on patients and payers.
    Wedzicha JA; Wilkinson T
    Proc Am Thorac Soc; 2006 May; 3(3):218-21. PubMed ID: 16636088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Biomarkers in COPD--do we need them?].
    Batura-Gabryel H
    Pneumonol Alergol Pol; 2011; 79(2):144-50. PubMed ID: 21351067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multi-omics study on biomarker and pathway discovery of chronic obstructive pulmonary disease.
    Tang Y; Chen Z; Fang Z; Zhao J; Zhou Y; Tang C
    J Breath Res; 2021 Sep; 15(4):. PubMed ID: 34280912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An overview of the current management of chronic obstructive pulmonary disease: can we go beyond the GOLD recommendations?
    Cazzola M; Rogliani P; Puxeddu E; Ora J; Matera MG
    Expert Rev Respir Med; 2018 Jan; 12(1):43-54. PubMed ID: 29082808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unravelling the complexity of COPD by microRNAs: it's a small world after all.
    Osei ET; Florez-Sampedro L; Timens W; Postma DS; Heijink IH; Brandsma CA
    Eur Respir J; 2015 Sep; 46(3):807-18. PubMed ID: 26250493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute exacerbations of chronic obstructive pulmonary disease: causes and impacts.
    Chhabra SK; Dash DJ
    Indian J Chest Dis Allied Sci; 2014; 56(2):93-104. PubMed ID: 25230550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.